Phase I Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 07 Jul 2017
At a glance
- Drugs PM 060184 (Primary) ; Gemcitabine
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors PharmaMar
- 03 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Jul 2019.
- 03 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jul 2019.
- 01 Sep 2015 New trial record